IMPDH1 and cervical carcinoma: Higher IMPDH1 expression is linked to poorer prognosis in renal cancer, liver cancer, urothelial cancer, glioma, and cervical cancer, while high IMPDH2 levels associate with poor prognosis in liver cancer.